keyword
https://read.qxmd.com/read/38622477/muc16-can-predict-the-pregnancy-outcomes-in-human-and-intraperitoneal-administration-of-muc16-can-rescue-pregnancy-losses-in-mouse-models
#21
JOURNAL ARTICLE
Xiaona Huang, Huizhen Lin, Yue Zhao, Peixin Wang, Hanqi Ying, Songying Zhang, Liu Liu
Mucin 16 (MUC16) participates in the process of embryo implantation, but few studies have examined the association between MUC16 and pregnancy loss. To investigate this association, the expression of MUC16 in serum and decidua was compared between women with pregnancy loss and ongoing pregnancies. In vitro experiments and animal models were used to explore the role and underlying mechanisms of MUC16 in pregnancy loss. In human study, the expression of MUC16 in serum and decidua was both consistently lower in the women with pregnancy loss compared with those in women with ongoing pregnancies...
April 15, 2024: Reproductive Sciences
https://read.qxmd.com/read/38622118/identification-of-a-novel-form-of-caspase-independent-cell-death-triggered-by-bh3-mimetics-in-diffuse-large-b-cell-lymphoma-cell-lines
#22
JOURNAL ARTICLE
Nahide Yildirim, Lakshmi Sarojam, Victoria M Smith, Nadja M Pieper, Marius Anders, Ross A Jackson, Dominik C Fuhrmann, Vinzenz Särchen, Daniela Brücher, Andreas Weigert, Martin J S Dyer, Meike Vogler
BH3-mimetics represent promising anti-cancer agents in tumors that rely on the anti-apoptotic function of B-Cell Lymphoma 2 (BCL2) proteins, particularly in leukemia and lymphoma cells primed for apoptosis. Mechanistically, BH3-mimetics may displace pro-apoptotic binding partners thus inducing BAX/BAK-mediated mitochondrial permeabilization followed by cytochrome c release, activation of the caspase cascade and apoptosis. Here, we describe a novel mode of caspase-independent cell death (CICD) induced by BH3-mimetics in a subset of diffuse large B-cell lymphoma (DLBCL) cells...
April 15, 2024: Cell Death & Disease
https://read.qxmd.com/read/38621981/-effect-of-spatholobi-caulis-extract-from-ethyl-acetate-on-immune-killing-function-of-nk-cells
#23
JOURNAL ARTICLE
Li-Na Yang, Yang Zhang, Xin-Ke DU, Li Liu, Jing Zhang, Qing Yang, Li-Dong Sun, Xiao-Xin Zhu, Qi Li
This study aims to investigate the regulatory effect of the Spatholobi Caulis extract from ethyl acetate(SEA) on natural killer(NK) cells under physiological conditions and elucidate the underlying mechanism. The C57BL/6 mice were randomized into NC and SEA groups, and NK-92 cells were respectively treated with 0, 25, 50, and 100 μg·mL~(-1) SEA. The body weight and immune organ index of the mice were compared between groups. The lactate dehydrogenase(LDH) assay was employed to examine the cytotoxicity of NK-92 cells treated with SEA and the killing activity of mouse NK cells against YAC-1 cells...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621464/traditional-herbal-medicine-therapeutic-potential-in-acute-gouty-arthritis
#24
REVIEW
Siwei Wang, Wei Liu, Bowen Wei, Aihua Wang, Yiwen Wang, Wen Wang, Jingyue Gao, Yue Jin, Hang Lu, Yuxiu Ka, Qingyun Yue
ETHNOPHARMACOLOGICAL RELEVANCE: Acute Gouty Arthritis (AGA) is characterized by a rapid inflammatory reaction caused by the build-up of monosodium urate (MSU) crystals in the tissues surrounding the joints. This condition often associated with hyperuricemia, is distinguished by its symptoms of intense pain, active inflammation, and swelling of the joints. Traditional approaches in AGA management often fall short of desired outcomes in clinical settings. However, recent ethnopharmacological investigations have been focusing on the potential of Traditional Herbal Medicine (THM) in various forms, exploring their therapeutic impact and targets in AGA treatment...
April 13, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38619971/repression-of-yeats2-induces-cellular-senescence-in-hepatocellular-carcinoma-and-inhibits-tumor-growth
#25
JOURNAL ARTICLE
Qi Wu, Quan Zheng, Lei Yuan, Dandan Gao, Yabing Hu, Xinqing Jiang, Qiaocheng Zhai, Ming Liu, Lifeng Xu, Heng Xu, Jinlin Ye, Feng Zhang
Hepatocellular carcinoma (HCC) stands as the third leading cause of cancer-related fatalities globally. In this study, we observed a significant increase in the expression level of the YEATS2 gene in HCC patients, and it is negatively correlated with the patients' survival rate. While we have previously identified the association between YEATS2 and the survival of pancreatic cancer cells, the regulatory mechanisms and significance in HCC are still to be fully elucidated. Our study shows that knockdown (KD) of YEATS2 expression leads to DNA damage, which in turn results in an upregulation of γ-H2A...
April 15, 2024: Cell Cycle
https://read.qxmd.com/read/38619967/functional-genomics-identifies-n-acetyllactosamine-extension-of-complex-n-glycans-as-a-mechanism-to-evade-lysis-by-natural-killer-cells
#26
JOURNAL ARTICLE
Xiaoxuan Zhuang, James Woods, Yanlong Ji, Sebastian Scheich, Fei Mo, Sumati Rajagopalan, Zana A Coulibaly, Matthias Voss, Henning Urlaub, Louis M Staudt, Kuan-Ting Pan, Eric O Long
Natural killer (NK) cells are primary defenders against cancer precursors, but cancer cells can persist by evading immune surveillance. To investigate the genetic mechanisms underlying this evasion, we perform a genome-wide CRISPR screen using B lymphoblastoid cells. SPPL3, a peptidase that cleaves glycosyltransferases in the Golgi, emerges as a top hit facilitating evasion from NK cytotoxicity. SPPL3-deleted cells accumulate glycosyltransferases and complex N-glycans, disrupting not only binding of ligands to NK receptors but also binding of rituximab, a CD20 antibody approved for treating B cell cancers...
April 14, 2024: Cell Reports
https://read.qxmd.com/read/38619272/virological-innate-and-adaptive-immune-profiles-shaped-by-variation-in-route-and-age-of-host-in-murine-cytomegalovirus-infection
#27
JOURNAL ARTICLE
Christopher P Coplen, Mladen Jergovic, Elana L Terner, Christine M Bradshaw, Jennifer L Uhrlaub, Janko Ž Nikolich
UNLABELLED: Human cytomegalovirus (hCMV) is a ubiquitous facultative pathogen, which establishes a characteristic latent and reactivating lifelong infection in immunocompetent hosts. Murine CMV (mCMV) infection is widely used as an experimental model of hCMV infection, employed to investigate the causal nature and extent of CMV's contribution to inflammatory, immunological, and health disturbances in humans. Therefore, mimicking natural human infection in mice would be advantageous to hCMV research...
April 15, 2024: Journal of Virology
https://read.qxmd.com/read/38618731/role-of-natural-killer-cells-as-cell-based-immunotherapy-in-oral-tumor-eradication-and-differentiation-both-in-vivo-and-in-vitro
#28
JOURNAL ARTICLE
Kawaljit Kaur, Anahid Jewett
Despite advancements in the field of cancer therapeutics, the five-year survival rate remains low in oral cancer patients. Therefore, the effective therapeutics are needed against oral cancer. Also, several studies including ours, have shown severely suppressed function and number of NK cells in oral cancer patients. In this review, we discuss the approach to inhibit the tumor growth and metastasis by direct killing or NK cell-mediated tumor differentiation. This review also provides an overview on supercharging NK cells using osteoclasts and probiotic bacteria, and their efficacy as cancer immunotherapeutic in humanized-BLT mice...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38618730/current-and-future-states-of-natural-killer-cell-based-immunotherapy-in-hepatocellular-carcinoma
#29
JOURNAL ARTICLE
Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven S Raman, Anahid Jewett, Jason Chiang
Natural killer (NK) cells are innate lymphoid cells that exhibit high levels of cytotoxicity against NK-specific targets. NK cells also produce various cytokines, and interact with T cells, B cells, and dendritic cells to effectively serve as frontliners of the innate immune system. Produce various cytokines, and interact with T cells, B cells, and dendritic cells to effectively serve as frontliners of the innate immune system. Moreover, NK cells constitute the second most common immune cell in the liver. These properties have drawn significant attention towards leveraging NK cells in treating liver cancer, especially hepatocellular carcinoma (HCC), which accounts for 75% of all primary liver cancer and is the fourth leading cause of cancer-related death worldwide...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38618451/a-rare-case-of-extranodal-natural-killer-t-cell-lymphoma-nasal-type-associated-with-hemophagocytic-lymphohistiocytosis-in-a-patient-with-recurrent-sinusitis
#30
Bryce R Christensen, Chung-Ting J Kou, Lauren E Lee
We present a rare case of hemophagocytic lymphohistiocytosis (HLH) secondary to nasal-type extranodal natural killer/T-cell lymphoma (ENKL). Nasal-type ENKL is a rare subtype of non-Hodgkin's lymphoma usually associated with Epstein-Barr virus (EBV). The patient was a 19-year-old woman who presented with facial numbness, diminished hearing, and dysgeusia. She was febrile with palatal necrosis, loss of gag reflex, and cranial nerve palsies. Labs revealed neutropenia. Broad-spectrum antimicrobials, including amphotericin, were started...
March 2024: Curēus
https://read.qxmd.com/read/38618203/camrelizumab-chemotherapy-and-apatinib-in-the-neoadjuvant-treatment-of-resectable-oesophageal-squamous-cell-carcinoma-a-single-arm-phase-2-trial
#31
JOURNAL ARTICLE
Zixiang Wu, Chuanqiang Wu, Jing Zhao, Cong Wu, Haixian Peng, Qi Wang, Rui Bai, Xuefeng Fang, Hong He, Hong Shen, Ming Wu
BACKGROUND: In resectable oesophageal squamous cell carcinoma (ESCC), the efficacy of camrelizumab combined with chemotherapy and apatinib followed by minimally invasive oesophagectomy is not clear. We aimed to fill this knowledge gap. METHODS: This investigator-initiated, single-arm, prospective, phase 2 trial was performed at the Second Affiliated Hospital of Zhejiang University, China. Patients (aged 18-75 years) who were histologically or cytologically diagnosed with ESCC were deemed suitable to participate in this trial...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38617521/ccnd2-is-a-prognostic-biomarker-and-correlates-with-immune-infiltration-in-lung-adenocarcinoma
#32
JOURNAL ARTICLE
Erna Jia, Xianquan Shi, Jinru Xue
BACKGROUND: CCND2 expression influences the growth and proliferation of cancer cells and plays a crucial role in immune response of tumor. However, few studies focused on the correlation between CCND2 and lung adenocarcinoma (LUAD) in terms of prognosis and tumor immune infiltration. METHODS: Original LUAD case data were screened from The Cancer Genome Atlas (TCGA) database. Using R software, we analyzed differently expressed CCND2 between LUAD and adjacent normal tissues...
March 31, 2024: Translational Cancer Research
https://read.qxmd.com/read/38616114/maitake-beta-glucan-enhances-the-therapeutic-effect-of-trastuzumab-via-antibody-dependent-cellular-cytotoxicity-and-complement-dependent-cytotoxicity
#33
JOURNAL ARTICLE
Yuki Masuda, Shizuka Yamashita, Yoshiaki Nakayama, Ryohei Shimizu, Morichika Konishi
Trastuzumab, an anti-HER2 monoclonal antibody, is the mainstay treatment for of HER2-positive breast cancer. However, trastuzumab resistance is often observed during treatment. Therefore, new therapeutic strategies are needed to enhance the clinical benefits of trastuzumab. Maitake β-glucan MD-Fraction, isolated from Grifola frondosa, inhibits tumor growth by enhancing immune responses. In this study, we examined the effect of MD-Fraction on trastuzumab treatment of HER2-positive breast cancer. MD-Fraction did not directly inhibit the survival of HER2-positive breast cancer cells, alone or in the presence of trastuzumab in vitro...
2024: Biological & Pharmaceutical Bulletin
https://read.qxmd.com/read/38615584/efficacy-and-safety-of-cell-based-immunotherapy-in-the-treatment-of-recurrent-or-metastatic-nasopharyngeal-carcinoma-a-systematic-review-and-meta-analysis
#34
JOURNAL ARTICLE
Brian Sheng Yep Yeo, Rachel Siying Lee, Nicholas E-Kai Lim, Ethan Tan, Isabelle Jia Hui Jang, Han Chong Toh, Chwee Ming Lim
BACKGROUND: Recurrent/Metastatic Nasopharyngeal Carcinoma (RM-NPC) remains difficult to treat and contributes to considerable mortality. The first-line treatment for RM-NPC is Gemcitabine and Cisplatin and second-line treatment options differ. The endemic variant of NPC is associated with Epstein-Barr Virus (EBV). Therefore, Cell-based Immunotherapy (CBI) targeting EBV-specific RM-NPC may be effective. METHODS: We systematically searched PubMed, Embase and the Cochrane Library for randomised or observational studies investigating the efficacy and safety of CBI in the treatment of RM-NPC...
April 13, 2024: Oral Oncology
https://read.qxmd.com/read/38615318/nkp44-hla-dp-dependent-regulation-of-cd8-effector-t%C3%A2-cells-by-nk-cells
#35
JOURNAL ARTICLE
Benedetta Padoan, Christian Casar, Jenny Krause, Christoph Schultheiss, Martin E Baumdick, Annika Niehrs, Britta F Zecher, Maria Pujantell, Yuko Yuki, Maureen Martin, Ester B M Remmerswaal, Tamara Dekker, Nelly D van der Bom-Baylon, Janelle A Noble, Mary Carrington, Frederike J Bemelman, Rene A W van Lier, Mascha Binder, Nicola Gagliani, Madeleine J Bunders, Marcus Altfeld
Although natural killer (NK) cells are recognized for their modulation of immune responses, the mechanisms by which human NK cells mediate immune regulation are unclear. Here, we report that expression of human leukocyte antigen (HLA)-DP, a ligand for the activating NK cell receptor NKp44, is significantly upregulated on CD8+ effector T cells, in particular in human cytomegalovirus (HCMV)+ individuals. HLA-DP+ CD8+ T cells expressing NKp44-binding HLA-DP antigens activate NKp44+ NK cells, while HLA-DP+ CD8+ T cells not expressing NKp44-binding HLA-DP antigens do not...
April 12, 2024: Cell Reports
https://read.qxmd.com/read/38614225/lymphocyte-antigen-96-a-new-potential-biomarker-and-immune-target-in-parkinson-s-disease
#36
JOURNAL ARTICLE
Haoran Peng, Longyu Wu, Siyuan Chen, Shaopu Wu, Xiaoxue Shi, Jianjun Ma, Hongqi Yang, Xue Li
BACKGROUND: Lymphocyte antigen 96 (LY96) plays an important role in innate immunity and has been reported to be associated with various neurological diseases. However, its role in Parkinson's disease (PD) remains unclear. METHODS: Transcriptome data from a total of 49 patients with PD and 34 healthy controls were downloaded from the Gene Expression Omnibus (GEO) database to analyse the expression pattern of LY96 and its relationship with gene function and immune-related markers...
April 11, 2024: Experimental Gerontology
https://read.qxmd.com/read/38614094/a-comprehensive-single-cell-breast-tumor-atlas-defines-epithelial-and-immune-heterogeneity-and-interactions-predicting-anti-pd-1-therapy-response
#37
JOURNAL ARTICLE
Lily Xu, Kaitlyn Saunders, Shao-Po Huang, Hildur Knutsdottir, Kenneth Martinez-Algarin, Isabella Terrazas, Kenian Chen, Heather M McArthur, Julia Maués, Christine Hodgdon, Sangeetha M Reddy, Evanthia T Roussos Torres, Lin Xu, Isaac S Chan
We present an integrated single-cell RNA sequencing atlas of the primary breast tumor microenvironment (TME) containing 236,363 cells from 119 biopsy samples across eight datasets. In this study, we leverage this resource for multiple analyses of immune and cancer epithelial cell heterogeneity. We define natural killer (NK) cell heterogeneity through six subsets in the breast TME. Because NK cell heterogeneity correlates with epithelial cell heterogeneity, we characterize epithelial cells at the level of single-gene expression, molecular subtype, and 10 categories reflecting intratumoral transcriptional heterogeneity...
April 9, 2024: Cell reports medicine
https://read.qxmd.com/read/38613330/retrospective-review-of-the-toxicities-and-change-in-dosing-patterns-for-pegaspargase-in-patients-with-acute-lymphoblastic-leukemia-lymphoma-and-t-cell-lymphoma
#38
JOURNAL ARTICLE
Grace Baek, Miryoung Kim, Madison Lee, Shan O'Connor, Lauren Held, Lars van der Laan, Ryan D Cassaday
INTRODUCTION: Pegaspargase (PEG) is a key component of standard regimens for acute lymphoblastic leukemia/lymphoma (ALL) and extranodal natural killer/T-cell lymphoma (NKTCL). Emerging evidence suggests an opportunity to decrease incidence of PEG-associated toxicities with dose capping, but evidence is limited. This study aims to evaluate whether a significant difference in PEG-associated toxicities related to dosing strategy exists and to identify patient-specific or regimen-specific factors for PEG-related toxicity...
April 13, 2024: Journal of Oncology Pharmacy Practice
https://read.qxmd.com/read/38612935/soluble-nkg2dls-are-elevated-in-breast-cancer-patients-and-associate-with-disease-outcome
#39
JOURNAL ARTICLE
Anna Seller, Christian M Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas D Hartkopf, Markus Hahn, Sara Y Brucker, Helmut R Salih, Melanie Märklin
Ligands of the natural killer group 2D (NKG2DL) family are expressed on malignant cells and are usually absent from healthy tissues. Recognition of NKG2DLs such as MICA/B and ULBP1-3 by the activating immunoreceptor NKG2D, expressed by NK and cytotoxic T cells, stimulates anti-tumor immunity in breast cancer. Upregulation of membrane-bound NKG2DLs in breast cancer has been demonstrated by immunohistochemistry. Tumor cells release NKG2DLs via proteolytic cleavage as soluble (s)NKG2DLs, which allows for effective immune escape and is associated with poor prognosis...
April 8, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612911/informed-by-cancer-stem-cells-of-solid-tumors-advances-in-treatments-targeting-tumor-promoting-factors-and-pathways
#40
REVIEW
Maya R MacLean, Olivia L Walker, Raj Pranap Arun, Wasundara Fernando, Paola Marcato
Cancer stem cells (CSCs) represent a subpopulation within tumors that promote cancer progression, metastasis, and recurrence due to their self-renewal capacity and resistance to conventional therapies. CSC-specific markers and signaling pathways highly active in CSCs have emerged as a promising strategy for improving patient outcomes. This review provides a comprehensive overview of the therapeutic targets associated with CSCs of solid tumors across various cancer types, including key molecular markers aldehyde dehydrogenases, CD44, epithelial cellular adhesion molecule, and CD133 and signaling pathways such as Wnt/β-catenin, Notch, and Sonic Hedgehog...
April 7, 2024: International Journal of Molecular Sciences
keyword
keyword
98900
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.